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ABSTRACT   
We examined poly--glutamate from natto, a Japanese fermented food, in the ability to adsorb 
Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2).  The polymer was immobilized by direct 
coupling to EAH-SepharoseTM.  The poly--glutamate-Sepharose (about 10 mg of ligand/mL 
of gel) adsorbed Stx2, but not Stx1: its dissociation constant (Kd) against Stx2 was calculated 
to be 14.0 M.  To analyze the binding site of poly--glutamate against Stx2, we similarly 
immobilized glutamate and glutarate.  Glutamate- and glutarate-Sepharoses (each 7 mol of 
ligand/mL of gel) similarly adsorbed Stx2, but not Stx1; Kd values against Stx2 were 
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calculated to be 14.0 and 30.0, respectively, M.  The common structures of PGA-, 
glutamate-, and glutarate-Sepharoses were considered to be glutaryl groups.  When we 
added the mixture of Stx2 and poly--glutamate-Sepharose to Caco-2 cells (a human colon 
epithelial cell line), poly--glutamate-Sepharose was found to reduce the cytotoxicity of Stx2.   
 
PRACTICAL APPLICATION 
Poly--glutamate is a component of a traditional Japanese food, and is believed to be 
absolutely safe.  Present study revealed that immobilized poly--glutamate adsorbed Stx2 
produced by enterohemorrhagic Escherichia coli.  To our knowledge, this is the first report 
on adsorbents specific to Stx2.  Our results are probably useful for development of new 
functional foods with the ability to adsorb Stx2.      
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INTRODUCTION 
Poly--glutamate (PGA) is a component of a traditional Japanese food, natto, prepared from 
steamed soybeans by the biological action of Bacillus subtilis.  PGA is an anionic 
polypeptide in which glutamate is polymerized via -amide linkages.  Therefore, PGA is 
indigestible, and is believed to be absolutely safe.  Potential applications of PGA have been 
of interest in a broad range of industrial fields such as medicine, food, and cosmetics (Shih & 
Van 2001; Bajaj & Singhal 2011).   
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 was first recognized as a food-
borne pathogen in 1982 (Riley et al. 1983).  EHEC O157:H7 is a member of a large group of 
Shiga toxin (Stx)-producing E. coli.  A general symptom of the diseases caused by EHEC is 
hemorrhagic diarrhea in human, and Stx produced in the gut lumen is closely related to the 
intestinal diseases.  The toxins also traverse the epithelium, invade the blood circulation, and 
cause neurological damage and hemolytic-uremic syndrome.  Since some of the antibiotics 
used for the treatment of EHEC infection were reported to activate toxin genes and induce the 
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release of accumulated intracellular toxin (Walterspiel et al. 1992), new types of therapeutic 
agents are required to this pathogen.   
EHEC O157:H7 produces two types of Stx, Stx1 and Stx2.  The amino acid sequence 
identity between Stx1 and Stx2 is about 56%, and they are immunologically distinct from 
each other (Bergan et al. 2012).  Several variants of both Stx1 and Stx2 have also been 
identified (Bergan et al. 2012; Melton-Celsa 2014).  Stx1 has been linked to human illness, 
but Stx2 are more frequently associated with the development of hemorrhagic colitis and 
hemolytic uremic syndrome (Melton-Celsa 2014).  Louise & Obrig (1995) reported that Stx2 
was 1000 times more cytotoxic than Stx1 toward human renal microvascular endothelial cells, 
the putative target of Stx.  Both Stx1 and Stx2 belong to the AB5 family of protein toxins, 
with one toxic subunit (A subunit) and five sugar recognizing subunits (B subunit) (Donohue-
Rolfe et al. 1991).  The B subunit pentamer binds to globotriaosylceramide (Gb3) on the cell 
surface of renal endothelial cells, and ferries the A subunit into the cells (Lingwood et al. 
1987).  Although Stx1 and Stx2 showed a similar affinity to soluble Gb3 (Kitova et al. 
2007), lipid environment around Gb3 is reported to influence the binding affinity of Stx1 and 
Stx2 to Gb3 (Bergan et al. 2012; Karve & Weiss 2014).  Cholesterol and 
phosphatidylcholine were reported to neutralize the cytotoxicity of Stx1, but not Stx2 
(Gallegos et al. 2012).  The binding ability of Stx1 to Gb3 under the lipid environment may 
be lower than that of Stx2.  Interaction between the toxins and Gb3 is reported to be 
multivalent; three binding sites on each B subunit monomer for Gb3 (Fraser et al. 2004; Ling 
et al. 1998).  Stx is also reported to bind to the P1 blood group antigen that is present in 
human erythrocyte glycolipid extracts (Jacewicz et al. 1986), and ovomucoid from pigeon egg 
white with the antigen is reported to adsorb Stx1(Miyake et al. 2000).  Although several 
polymers including the globotriose moiety of Gb3 have been reported to adsorb Stx (Miyake 
et al. 2000; Li et al. 2012; Miyagawa et al. 2006; Nishikawa et al. 2002; Watanabe et al. 
2004), there are few reports on foods with an ability to adsorb Stx.  Previously, we reported 
that Stx bound to PGA precipitated beyond the saturated density, but not to soluble PGA 
(Goto et al. 2016).  If chemically insolubilized PGA adsorbs Stx, the toxin in gut lumen may 
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be excreted with the PGA into feces.  To obtain an insoluble PGA as a functional food with 
ability to adsorb Stx, we prepared and analyzed PGA-Sepharose and related resins. 
  
MATERIALS AND METHODS 
 
Materials  
PGA was purified from natto as described previously (Goto et al. 2016).  EAH-SepharoseTM 
4B was obtained from GE healthcare, Uppsala, Sweden.  1-Ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC), glutamic acid and glutaric acid were from 
Nakarai tesque Co., Kyoto, Japan.  Dowex Mac 3 (3.8 mol of carboxyl groups/mL of 
resin), an anion-exchange resin, was obtained from Dow Chemical Japan, Tokyo, Japan.  An 
Stx (VT) detection kit including Stx1 and Stx2 as references (variants: Stx1a and Stx2a) was 
obtained from Denka Seiken (Tokyo, Japan).  Float-A-Lyzer G2 (MWCO=300K) was 
obtained from Spectrum Labs Com (Rancho Dominquez, CA, USA).  Amicon Ultra-4 and 
Amicon Ultra-15 (MWCO: 10 kDa and 100 kDa) were obtained from Merck Millipore 
(Billerica, Mass. USA).  Millex-GV (pore size 0.22 μm) was also obtained from Merck 
Millipore (Billerica, Mass. USA).  The 96-well microplates (V-bottom) used for a reversed 
passive latex agglutination (RPLA) assay of Stx was supplied from Greiner Japan (Tokyo, 
Japan).  Caco-2 (a human colon epithelial cell line) was obtained from DS Pharma 
Biomedical Co. Ltd., Tokyo, Japan.  A minimum essential medium (MEM), fetal bovine 
serum (FBS), and non-essential amino acids (NEAA) were obtained from Thermo Fisher 
Scientific (Yokohama, Japan).  Cell counting kit-8 was purchased from Dojindo (Kumamoto, 
Japan). 
 
Preparation of immobilized PGA 
PGA was immobilized by direct coupling to EAH-SepharoseTM 4B with EDC.  Six mL of 
EAH-SepharoseTM 4B (10 mole amino groups/mL of gel) was mixed with 6 mL of PGA 
solution (10 mg/mL, pH 5.0) and solid EDC (228 mg, final conc. 0.1 M), and incubated at 
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25oC for 17 h.  During the initial 1 h of the reaction, the pH value of mixture was kept at 5.0 
according to the manufacture’s protocol.  After the reaction, the resin was washed three 
times with 10 mL of distilled water and kept at 4°C until use.  About 10 mg of PGA was 
found to be immobilized on 1 mL of gel, as judged from increase in weight of dried resin 
before and after the immobilized reaction.  Glutamate-Sepharose and glutarate-Sepharose 
were similarly prepared: about 1.5 mg ligands were immobilized on mL of gel. 
 
RPLA assay of Stx 
The amounts of Stx1 and Stx2 were determined by RPLA assay with 96-well microplates (V-
bottom) and the Stx detection kit as previously reported (Takemasa et al. 2009).  The lower 
detection limit of 1 ng/mL of Stx was confirmed with the references Stx1 and Stx2 provided 
in the kit.  The sample solutions containing Stx were subjected to twofold serial dilution, and 
each diluted sample (25 L) was mixed with the suspension (25 L) of latex beads coated 
with anti-Stx1a or anti-Stx2a antibody in 96-well microplates.  After incubating the 
microplates at 30°C overnight, the agglutination of latex beads in each well was examined 
with the naked eye.  The reciprocal of the maximal dilution rate showing agglutination was 
expressed as RPLA titers of Stx1 and Stx2 in the original samples. 
 
Determination of Kd values 
We analyzed PGA-, glutamate-, and glutarate-Sepharoses in the ability to adsorb Stx by an 
equilibrated dialysis method with Float-A-Lyzer G2 as described previously (Badr et al. 
2017).  The references Stx1 and Stx2 with a molecular weight of about 72 kDa were 
dissolved in 10 mM phosphate buffer (pH 7.4) supplemented with 0.85% NaCl and 0.5% 
bovine serum albumin (BSA) to avoid non-specific adsorption.  A constant amount of each 
resin (0.2 mL) and varying concentrations of Stx solutions (0.2 mL) were mixed, put in the 
dialysis bag of the Float-A-Lyzer G2, and dialyzed against 50 mL of 10 mM phosphate buffer 
(pH 7.4) supplemented with 0.85% NaCl and 0.5% BSA at 4°C for 16 h.  After the dialysis, 
the outer liquid was concentrated with a filter unit (Amicon Ultra-15, MWCO: 10 kDa), and 
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subjected to the RPLA assay.  The Stx bound to the resins in the dialysis bag was dissociated 
by addition of NaOH (final pH 10), and free Stx was separated from the resins by the 
centrifugal ultrafiltration with a filter unit (Amicon Ultra-4, MWCO: 100 kDa).  After the 
ultrafiltration at 4,000 g for 30 min, filtrates containing free Stx were neutralized with HCl 
and analyzed by the RPLA assay.  The ratio () of [bound Stx] to [the Stx-adsorbent] was 
plotted against  /[free Stx].  The Kd values were obtained by calculating the reciprocal of 
slopes of lines, as described previously (Badr et al. 2017). 
  
Preparation of crude Stx 
Stx1 localized in the periplasm fraction of bacterial cells and Stx2 secreted into culture media 
(Shimizu et al. 2007) were separately prepared.  EHEC O157:H7 Sakai was aerobically 
cultivated at 37°C for 24 h in 20 mL of Luria-Bertani (LB) medium (1% tryptone, 0.5% yeast 
extract, 0.5% NaCl, and 1 mM NaOH).  After centrifugation of the culture at 10,000 g for 15 
min, the supernatant solution obtained was sterilized with a filter unit (Millex-GV, pore size 
0.22 μm) and used as extracellular Stx preparation.  The precipitated cells were suspended in 
2 mL of 10 mM phosphate buffer (pH 7.4) and disrupted by vigorous mixing with 1 g of glass 
beads (average diameter of 0.1 mm).  After centrifugation of the cell extract at 10,000 g for 
15 min, the supernatant solution obtained was sterilized with the filter unit and used as an 
intracellular Stx preparation.  The extracellular and intracellular Stx preparations were 
mixed, dialyzed against 10 mM phosphate buffer (pH 7.4) and used as a crude Stx (a mixture 
of Stx1 and Stx2).  
 
Specificity of PGA-Sepharose against Stx  
The crude Stx was put on a PGA-Sepharose column ( 0.5 x 5 cm) equilibrated with 10 mM 
phosphate buffer (pH 7.4).  After the column was washed with the same buffer, elution was 
made by a linear gradient of 0-20 mM NaOH at a flow rate of 1.0 mL/min.  After 
neutralization of eluate with HCl, the amounts of Stx1 and Stx2 in fractions were determined 
by the RPLA assay.    
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Protection of Caco-2 cells by PGA-Sepharose from Stx2 
We prepared the Stx2 bound to PGA-Sepharose, and examined the cytotoxicity of the 
complex as follows.  Mixtures of PGA-Sepharose (40 L of 10% suspension) and several 
concentrations of Stx2 solutions (40 L) were incubated at 37°C for 1 h with shaking.  After 
the incubation, the mixture was directly used for the cell based assay with Caco-2 cells.  
Caco-2 cells were inoculated in 96 well microplates (about 250 cells/well) with 45 L MEM 
containing 20% FBS and 0.1ｍM NEAA.  After incubation at 37°C for 2 h in a humidified 
atmosphere with 5% CO2, 5 L of the mixture was added into each well.  The cells were 
cultured at 37°C for 4 days in a humidified atmosphere with 5% CO2.  Living cells in each 
well were measured with Cell counting kit-8 according to the manufacture’s protocol.   
 
Statistical analysis 
Three independent experiments were performed twice, and the results (n = 6) were analyzed 
by analysis of variance (ANOVA) using a software, StatView (SAS Institute, Inc., Cary, NC, 
USA).  
 
RESULTS  
 
Binding of Stx to PGA-Sepharose 
We examined the binding of Stx to PGA-Sepharose by the equilibrated dialysis method.   
Fig. 1A showed the binding of Stx2 to PGA-Sepharose.  The amounts of Stx2 bound to 
PGA-Sepharose increased with increase of those of Stx2 used.  The Kd value of PGA-
Sepharose against Stx2 was obtained by calculating the reciprocal of slope of the line in Fig. 
1B, and shown in Table 1.  However, Stx1 did not bind to PGA-Sepharose (data not shown).   
Similarly, we examined the binding of Stx against glutamate-Sepharose, glutarate-
Sepharose and Dowex Mac 3.  Figure 2A showed the adsorption of Stx2 to glutamate-
Sepharose.  The Kd value of glutamate-Sepharose to Stx2 was similarly calculated based 
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upon the results of Fig. 2B and was identical to that of PGA-Sepharose (Table 1).  Figure 3A 
showed the binding of Stx2 to glutarate-Sepharose.  Stx1 did not bind to glutamate- and 
glutarate-Sepharoses (data not shown).  We also calculated the Kd value of glutarate-
Sepharose against Stx2 based upon the results of Fig. 3B.  The glutarate-Sepharose showed a 
similar Kd value to PGA- and glutamate-Sepharoses (Table 1).  While, neither Stx1 nor Stx2 
bound to Dowex Mac 3 (data not shown).   
 
Specificity of PGA-Sepharose against Stx 
As described above, PGA-Sepharose bound Stx2, but not Stx1.  We examined the specificity 
of PGA-Sepharose against Stx2 by the column chromatography.  The crude Stx containing 
each 100 ng of Stx1 and Stx2 (1 mL) was applied to the column.  As shown in Fig. 4, Stx1 
was passed through the column, but Stx2 was adsorbed to the column and eluted with about 
10 mM NaOH.  The yields of Stx1 and Stx2 were both about 100%.  When more than 100 
ng of Stx2 were put on the column, a part of Stx2 passed through the column.   
 
Protection of Caco-2 cells by PGA Sepharose from Stx2 
Figure 5 shows the effect of PGA-Sepharose on protection of Caco-2 cells from Stx2.  We 
confirmed in advance that PGA-Sepharose induced neither increase nor decrease of the living 
cells number of Caco-2 cells.  The number of living cells decreased with increase of the 
concentration of Stx2.  However, the mixtures of Stx2 and PGA-Sepharose seemed to have 
lower cytotoxicity than only Stx2.  Thus, Caco-2 cells were partially protected by PGA-
Sepharose from cytotoxicity of Stx2.    
 
DISCUSSION 
    
     PGA-Sepharose bound Stx2, but not Stx1.  Isoelectric points of Stx1 and Stx2 were 
reported to be 7.0 and 4.1, respectively (Dickie et al. 1989; Oku et al. 1989).  Thus, Stx2 is 
an acidic protein.  The binding of Stx2 to PGA-Sepharose was considered not to be ionic 
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interaction.  Since glutamate-Sepharose also showed a similar affinity against Stx2 to PGA-
Sepharose, the binding between PGA-Sepharose and Stx2 seemed not to depend on the 
conformation of PGA (Shih & Van 2001).  In addition, amino groups of glutamate-Sepharose 
seemed not to influence on the binding of Stx2.  While, Dowex Mac 3 adsorbed neither Stx1 
nor Stx2.  The structure of polyacrylic acid seemed to be unsuitable for adsorbing Stx.   
We used EDC for the direct coupling of PGA, glutamic acid, and glutaric acid to EAH-
SepharoseTM 4B.  EDC is known to specifically react with carboxylic groups to yield o-
acylisourea active esters those specifically react with primary amino groups.  The active 
esters are unstable in the absence of amino groups, and easily release isourea as a by-product 
to yield original carboxylic groups (Grabarek & Gergely 1990).  Therefore, there is no 
modification in the PGA-Sepharose and other related resins except for cross-linking formed 
by the coupling reaction with EDC.  Since the Kd values of PGA-, glutamate-, and glutarate–
Sepharoses to Stx2 were similar to each other, the common binding site of Stx2 against these 
resins was considered to be glutaryl groups.   
There are several reports on Gb3 as an Stx-adsorbent for clinical practice.   Since 
interaction between Stx and Gb3 was reported to be multivalent (Fraser et al. 2004; Ling et al. 
1998), clustered Gb3 was required for strong binding (Nishikawa 2011).  Free Gb3 showed a 
low affinity to Stx (Kd value: about 1 mM) (St Hilaire et al. 1994), but a conjugate of Gb3-
chitosan was reported to have lower Kd values (0.05 M for Stx1B, 0.43 M for Stx2B) to 
Stx than free Gb3 (Li et al. 2012).  Thus, the Kd value of PGA-Sepharose as a functional 
food was higher than that of the Gb3-chitosan conjugate as a medicine.  However, our results 
are probably useful for development of functional foods with ability to prevent diseases 
caused by EHEC and to mitigate symptoms of the infectious disease, because functional foods 
can be taken in larger quantities than medicine.  Gallegos et al. (2012) reported that binding 
of Stx2 to Gb3 was influenced by residues in the ceramide portion of Gb3 and the lipid 
environment.  Karve & Weiss (2014) also reported that the binding of Stx variants increased 
in the presence of phosphatidylcholine and cholesterol.  Therefore, we examined the 
protective effect of PGA-Sepharose on the cytotoxicity of Stx2 with Caco-2 cells.  The cells 
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are widely used for investigating Stx-mediated intestinal cytotoxicity (Kouzel et al. 2017).  
We found that Caco-2 cells were partly protected by PGA-Sepharose from Stx2 under the 
conditions we used.  Because of the deference in affinities to Stx2 between Caco-2 cells and 
PGA-Sepharose, Stx2 bound to PGA-Sepharose may partly dissociate and exhibit the 
cytotoxicity to Caco-2 cells.  However, our results suggested that PGA-Sepharose had the 
ability to bind Stx2 even in the presence of Caco-2 cells.   
Difference in toxicity of Stx1 and Stx2 is speculated to be that in receptor binding 
preferences between the two toxins (Fraser et al. 2004; Ling et al. 1998; Karve & Weiss 
2014).  Since Stx2 has markedly higher toxicity than Stx1, removal of Stx2 from intestinal 
environment of patients is important for prevention and treatment of infectious diseases by 
EHEC.  However, there was no report about Stx2-adsorbents, to the best of our knowledge.  
PGA-Sepharose was found to specifically adsorb Stx2 when we used the crude Stx.     
     Our results are probably useful for development of new functional foods with the 
ability to adsorb Stx2.   
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Figure Legends 
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FIG. 1.  Binding of Stx2 to PGA-Sepharose by the equilibrated dialysis method. 
PGA-Sepharose (0.2 mL) and several concentrations of Stx solution (0.2 mL) were mixed, put 
in a bag of the Float-A-Lyzer G2 (MWCO = 300 K), and dialyzed against 50 mL of 10 mM 
phosphate buffer (pH 7.4) supplemented with 0.85% NaCl and 0.5% BSA at 4°C for 16 h.  
The amounts of Stx in the dialysis bag (bound Stx, open bars) and outer liquid (free Stx, 
closed bars) were analyzed by the RPLA assay (A). The ratios () of [bound Stx] to [PGA] 
were plotted against  /[free Stx] (B).  The Kd value was obtained by calculating the 
reciprocal of slope of a line in Fig. 1B.  Three independent experiments were performed 
twice, and the vertical bars show the standard errors. 
 
FIG. 2.  Binding of Stx2 to glutamate-Sepharose by the equilibrated dialysis method. 
Experiments were performed as described in Fig. 1 except that PGA-Sepharose was replaced 
with glutamate-Sepharose.  The amounts of Stx in the dialysis bag (bound Stx, open bars) 
and outer liquid (free Stx, closed bars) were analyzed by the RPLA assay (A). The ratios () 
of [bound Stx] to [glutamate] were plotted against  /[free Stx] (B).  The Kd value was 
obtained by calculating the reciprocal of slope of a line in Fig. 2B.  Three independent 
experiments were performed twice, and the vertical bars show the standard errors. 
 
FIG. 3.  Binding of Stx2 to glutarate-Sepharose by the equilibrated dialysis method. 
Experiments were performed as described in Fig. 1 except that PGA-Sepharose was replaced 
with glutarate-Sepharose.  The amounts of Stx in the dialysis bag (bound Stx, open bars) and 
outer liquid (free Stx, closed bars) were analyzed by the RPLA assay (A). The ratios () of 
[bound Stx] to [glutarate] were plotted against  /[free Stx] (B).  The Kd value was obtained 
by calculating the reciprocal of slope of a line in Fig. 3B.  Three independent experiments 
were performed twice, and the vertical bars show the standard errors. 
 
FIG. 4.  PGA-Sepharose column chromatography of Stx.  The crude Stx (each 100 ng of 
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Stx1 and Stx2, 1 mL) was put on a PGA-Sepharose column ( 0.5 cm x 5 cm, about 1 mL) 
equilibrated with 10 mM phosphate buffer (pH 7.4) at a flow rate of 1.0 mL/min.  After 
washing the column with the same buffer, elution was made by a linear gradient of 0-20 mM 
NaOH at a flow rate of 1.0 mL/min.  After neutralization of eluate with HCl, the amount of 
Stx in each fraction was determined by the RPLA assay.  Three independent experiments 
were performed, and the representative result was shown.  Black bar: Stx1, white bar: Stx2. 
 
FIG. 5.  Protection of Caco-2 cells by PGA Sepharose from Stx2.  Mixtures of PGA-
Sepharose (40 L of 10% suspension) and several concentrations of Stx2 solutions (40 L) 
were incubated at 37°C for 1 h with shaking.  The mixtures were directly used for the cell 
based assay with Caco-2 cells.  Caco-2 cells were inoculated in 96 well microplates (about 
250 cells/well) with 45 L MEM containing 20% FBS and 0.1 mM non-essential amino acids.  
After incubation at 37°C for 2 h in a humidified atmosphere with 5% CO2, 5 L of the mixture 
was added into each well.  As controls, the mixture was replaced with Stx2 solution or PGA-
Sepharose.  The cells were cultured at 37°C for 4 days in a humidified atmosphere with 5% 
CO2.  Living cells in each well were measured with the Cell counting kit-8 according to the 
manufacture’s protocol.  Six independent experiments were performed, and the vertical bars 
show the standard errors.  Closed circles: the mixture, open circles: Stx2, and closed 
triangles: PGA-Sepharose. 
 
 
 
 
 
 
 
 





Table 1  The Kd values of PGA-, glutamate-, and glutarate-Sepharoses to Stx2. 
Resins Kd (µM)                          
PGA-Sepharose 14.0 
Glutamate-Sepharose 14.0 
Glutarate-Sepharose 30.0                             
 
 
 
 
 
 
 
